Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β- d -ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis
Year: 2010
Type: article
Abstract: Benzothiazinones (BTZs) form a new class of potent antimycobacterial agents. Although the target of BTZs has been identified as decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), their detailed mechanism of action remains obscure. Here we demonstrate that BTZs are activated in the bacterium by reduction of an essential nitro group to a nitroso derivative, which then specifically reacts with a cysteine residue in the active site of DprE1.
DOI: 10.1021/ja106357w
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2004707638
